Incarceration and HIV-Infected Inmates
Incarceration and HIV-Infected Inmates
批准号:
7911756
负责人:
DAVID A WOHL
金额:
$29.98万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-19 至 2012-02-29
关键词:
AIDS preventionAIDS/HIV problemAcuteAfrican AmericanAreaAttentionBloodCaringCharacteristicsChronicConfidentialityConsentCounselingDataDecision MakingDevice or Instrument DevelopmentDiagnosisDiscipline of NursingEffectivenessEnrollmentEpidemicFigs - dietaryFrightGoalsHIVHIV AntibodiesHIV InfectionsHIV diagnosisHigh PrevalenceHighly Active Antiretroviral TherapyHuman immunodeficiency virus testImprisonmentIndividualInfectionInformation SystemsInterventionInvestigationJailLifeLiteratureMeasurementMeasuresMediator of activation proteinModelingNorth CarolinaNursesOpportunistic InfectionsPatient Outcomes AssessmentsPersonsPlayPoliciesPopulationPredispositionPrevalencePreventionPrisonerPrisonsPrivacyProceduresProcessProfessional counselorProphylactic treatmentPublic HealthPunishmentQuestionnairesRaceResearchResearch PersonnelRiskRisk BehaviorsRoleSamplingSecuritySelf EfficacySeveritiesSiteSyphilis SerodiagnosisSystemTest ResultTestingTheoretical modelTraumaTrustUnited States Dept. of Health and Human ServicesViralantiretroviral therapydesignimprovedinstrumentinterestmedical schoolsphysical abuseprogramstherapy designtransmission processuptakevolunteer
中文摘要
描述(由申请人提供):在美国,每年有近20%的艾滋病毒感染者通过教养所。一些研究表明,囚犯中的艾滋病毒感染率比非监禁人口中的感染率高8至10倍,而且很大一部分囚犯的感染风险很高。自愿咨询和检测(VCT)的艾滋病毒感染风险的个人是一个有效的手段,初级和二级预防艾滋病毒。北卡罗来纳州惩教部(NCDOC)有一项自愿艾滋病毒检测政策,70%的新囚犯拒绝接受检测。与其他31个采用自愿检测的州监狱系统一样,这是一个失去识别感染者并将他们纳入护理的机会。不幸的是,我们缺少一些必要的信息,以确定被监禁者中艾滋病毒感染的真实患病率,并了解新被监禁者如何决定接受艾滋病毒检测。在医学和公共卫生学院的研究人员与NCDOC和北卡罗来纳州卫生与公众服务部(NCDHHS)的官员之间的合作努力中,我们将对大型州立监狱系统中艾滋病毒检测的障碍和促进因素进行全面评估。首先,我们将确定急性和慢性艾滋病毒感染的实际流行率在新入监狱的囚犯和艾滋病毒的危险行为的特点。第二,我们将研究最近被监禁的囚犯之间的自愿艾滋病毒检测和变量的摄取之间的关联在三个层面:个人囚犯,NCDOC护士辅导员和监狱处理设施。最后,我们将对在监狱中接受艾滋病毒诊断的相关风险进行初步审查。本申请中所述研究的最终目标是更清楚地了解艾滋病毒感染在这一人群中的影响,并为在这一背景下促进艾滋病毒自愿咨询和检测的干预措施的设计提供信息。具体而言,我们将:目标1。确定一个大型州立监狱系统中急性和慢性艾滋病毒感染的流行率。目标二。确定同意艾滋病毒VCT的囚犯,护士顾问和设施的特点。目标3.探讨在监狱中接受艾滋病毒诊断的相关风险。
英文摘要
DESCRIPTION (provided by applicant): Nearly 20% of all people infected with HIV in the US pass through a correctional facility each year. Several studies suggest that the prevalence of HIV infection among prisoners is between 8 and 10-fold higher than the prevalence in non-incarcerated populations and a significant proportion of inmates are at elevated risk for infection. Voluntary counseling and testing (VCT) of individuals at risk for HIV infection is an effective means of primary and secondary HIV prevention. The North Carolina Department of Corrections (NCDOC) has a voluntary HIV testing policy and 70% of all incoming inmates decline the opportunity to receive testing. As is the case for the other 31 state prison systems that employ voluntary testing, this is a lost opportunity to identify infected people and enroll them in care. Unfortunately, we are missing several pieces of information required both to determine the true prevalence of HIV infection among incarcerated people as well as to understand how newly incarcerated people make the decision to receive an HIV test. In a collaborative effort between researchers at the UNC Schools of Medicine and Public Health and officials at the NCDOC and the North Carolina Department of Health and Human Services (NCDHHS), we will perform a comprehensive assessment of the barriers and facilitators of HIV testing in a large state prison system. First, we will determine the actual prevalence of acute and chronic HIV infection among incoming inmates and characterize the HIV risk behaviors of this group. Second, we will examine the association between the uptake of voluntary HIV testing among recently incarcerated inmates and variables at three levels: individual inmate, NCDOC nurse-counselor and prison processing facility. Finally, we will conduct a preliminary examination of the risks associated with receiving an HIV diagnosis in prison. The ultimate goals of the studies described in this application are to obtain a clearer picture of the impact of HIV infection among this population and to inform the design of interventions to promote HIV VCT in this setting. Specifically, we will: Aim 1. Determine the prevalence of acute and chronic HIV infection in a large state prison system. Aim 2. Determine the inmate, nurse-counselor and facility characteristics associated with agreeing to HIV VCT. Aim 3. Explore the risks associated with receiving an HIV diagnosis in prison.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Opt-out HIV testing in prison: informed and voluntary?
选择退出监狱中的艾滋病毒检测:知情且自愿?
DOI:
10.1080/09540121.2014.989486
发表时间:
2015
期刊:
AIDS care
影响因子:
1.7
作者:
[Rosen,DavidL, Golin,CarolE, Grodensky,CatherineA, May,Jeanine, Bowling,JMichael, DeVellis,RobertF, White,BeckyL, Wohl,DavidA]
通讯作者:
Wohl,DavidA
DOI:
10.1007/s10461-015-1203-y
发表时间:
2016-04
期刊:
AIDS and behavior
影响因子:
4.4
作者:
[Grodensky CA, Rosen DL, Hino S, Golin CE, Wohl DA]
通讯作者:
Wohl DA
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
-
批准号:8731476
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2014
-
负责人:DAVID A WOHL
-
依托单位:
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
-
批准号:9084502
-
项目类别:
-
资助金额:$18.24万
-
财政年份:2014
-
负责人:DAVID A WOHL
-
依托单位:
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
-
批准号:9472311
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2014
-
负责人:DAVID A WOHL
-
依托单位:
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION
-
批准号:7716751
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: A5235 - MINOCYCLINE IN THE TREATMENT OF HIV-ASSOCIATED COGNITIVE
-
批准号:7716911
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: ENFURVITIDE (T-20) INTENSIFICATION FOR LOW LEVEL VIREMIA (THE LO
-
批准号:7716849
-
项目类别:
-
资助金额:$1.46万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: TWO DOSES OF GW433908/RITONAVIR GIVEN WITH ABACAVIR/LAMIVUDINE C
-
批准号:7716816
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
LONG-TERM ANTIVIRAL MANAGEMENT OF HCV AND HIV-1 COINFECTED SUBJECTS (SLAM-C)
-
批准号:7716808
-
项目类别:
-
资助金额:$0.73万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: MRK AD5 HIV-1 GAG VACCINE IN HIV-1 SUBJECTS WHO INTERUPT THERAPY
-
批准号:7716792
-
项目类别:
-
资助金额:$1.34万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
CLINICAL TRIAL: PHASE I/II URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY (ACTG A522
-
批准号:7716871
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2008
-
负责人:DAVID A WOHL
-
依托单位:
Incarceration and HIV-Infected Inmates
-
批准号:7679078
-
项目类别:
-
资助金额:$63.58万
-
财政年份:2007
-
负责人:DAVID A WOHL
-
依托单位:
Incarceration and HIV-Infected Inmates
-
批准号:7338067
-
项目类别:
-
资助金额:$47.14万
-
财政年份:2007
-
负责人:DAVID A WOHL
-
依托单位:
EZETIMIBE THERAPY FOR DYSLIPIDEMIA IN PATIENTS RECEIVING HIV THERAPY
-
批准号:7625596
-
项目类别:
-
资助金额:$4.69万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION
-
批准号:7625507
-
项目类别:
-
资助金额:$10.06万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
POTENT COMBINATION OF ANTIRETROVIRAL REGIMEN IN AFRICAN-AMERICAN MEN AND WOMEN
-
批准号:7625535
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
TWO DOSES OF GW433908/RITONAVIR GIVEN WITH ABACAVIR/LAMIVUDINE COMBO
-
批准号:7625607
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
PHASE II ONCE-WEEKLY ALENDRONATE IN HIV-INFECTED SUBJECTS WITH DECREASED BONE D
-
批准号:7625543
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
PHASE I/II URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY (ACTG A5229)
-
批准号:7625670
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
PHASE 3 COMPARISON OF LOPINAVIR/RITONAVIR EFAVIRENZ STAVUDINE LAMIVUDINE FOR INI
-
批准号:7625534
-
项目类别:
-
资助金额:$2.75万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位:
LONG-TERM ANTIVIRAL MANAGEMENT OF HCV AND HIV-1 COINFECTED SUBJECTS (SLAM-C)
-
批准号:7625588
-
项目类别:
-
资助金额:$2.86万
-
财政年份:2006
-
负责人:DAVID A WOHL
-
依托单位: